Identification of non-canonical peptides with moPepGen
- PMID: 40523945
- DOI: 10.1038/s41587-025-02701-0
Identification of non-canonical peptides with moPepGen
Abstract
Proteogenomics is limited by the challenge of modeling the complexities of gene expression. We create moPepGen, a graph-based algorithm that comprehensively generates non-canonical peptides in linear time. moPepGen works with multiple technologies, in multiple species and on all types of genetic and transcriptomic data. In human cancer proteomes, it enumerates previously unobservable noncanonical peptides arising from germline and somatic genomic variants, noncoding open reading frames, RNA fusions and RNA circularization.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: P.C.B. sits on the scientific advisory boards of Intersect Diagnostics and previously sat on those of Sage Bionetworks and BioSymetrics. The other authors declare no competing interests.
Update of
-
Identification of non-canonical peptides with moPepGen.bioRxiv [Preprint]. 2025 May 9:2024.03.28.587261. doi: 10.1101/2024.03.28.587261. bioRxiv. 2025. Update in: Nat Biotechnol. 2025 Jun 16. doi: 10.1038/s41587-025-02701-0. PMID: 38585946 Free PMC article. Updated. Preprint.
References
-
- Creighton, C. J. Clinical proteomics towards multiomics in cancer. Mass Spectrom. Rev. https://doi.org/10.1002/MAS.21827 (2022). - DOI - PubMed
Grants and funding
- P50CA092131/U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
- U2C CA271894/CA/NCI NIH HHS/United States
- R01CA244729/U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
- U24CA248265/U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
- P30CA016042/U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
LinkOut - more resources
Full Text Sources